UCL is a world-leader in the clinical translation of cell and gene therapies.
Treatment of disease using cell and gene therapy is now a reality. The UK, with London and UCL in particular, is at the forefront of developing cell and gene therapy for clinical application to a wide range of human genetic disorders.
UCL and partner NHS Trusts are the lead participant in clinical trials of advanced therapies in the UK, competing with prestigious US institutions and top European countries in terms of clinical activity. We are delivering multiple pioneering technologies, many first-in-human, across multiple disease areas.
Our multidisciplinary Cell, Gene and Regenerative Medicines Therapeutic Innovation Network has established a strong and diverse pipeline that is delivering to patients and to the UK’s industrial ambitions. Our strategic partnerships are pivotal to our success and we are continually seeking to create new, multidisciplinary alliances with patient-centric organisations from a variety of sectors.